BACKGROUND: Limited studies have examined the associations between mammographic density and subsequent breast tumor characteristics. METHODS: Eligible women were part of a case-control study of postmenopausal breast cancer, were 40 years or older and had a routine mammogram 4 years or more before their diagnosis. Mammographic density (percent density, dense area, and nondense area) was estimated using a computer-assisted thresholding program. At the time of cancer diagnosis, cases were classified as asymptomatic or symptomatic based on medical record review and breast imaging workup. Pathologic review was done blinded to the density status. Linear regression models and tests for trend examined the association between pathologic characteristics of the breast tumor and the components of density for all participants, and stratified by symptom status at diagnosis. RESULTS: Of the 286 eligible cases, 77% were 60 years or older and mean percent density was 29.5% (SD, 14.6%). Density was not significantly associated with tumor size (P = 0.22), histologic type (P = 0.77), estrogen receptor (P = 0.11) or progesterone receptor (P = 0.37) status, mitotic activity (P = 0.12), or nuclear pleomorphism (P = 0.09; P values for percent density). An inverse association was suggested between tumor grade and percent density (32.0%, 30.3%, 26.7% for grades 1-3; P = 0.06 for trend). The inverse association with tumor grade and its components (nuclear pleomorphism and tubular differentiation) was only evident among the 97 symptomatic women; positive associations of estrogen receptor (P = 0.009) and progesterone receptor (P = 0.04) were also seen with percent density only in this subgroup. CONCLUSIONS: The inverse association between tumor grade and percent density in the symptomatic population could inform the biology of the association between mammographic density and breast cancer risk.
BACKGROUND: Limited studies have examined the associations between mammographic density and subsequent breast tumor characteristics. METHODS: Eligible women were part of a case-control study of postmenopausal breast cancer, were 40 years or older and had a routine mammogram 4 years or more before their diagnosis. Mammographic density (percent density, dense area, and nondense area) was estimated using a computer-assisted thresholding program. At the time of cancer diagnosis, cases were classified as asymptomatic or symptomatic based on medical record review and breast imaging workup. Pathologic review was done blinded to the density status. Linear regression models and tests for trend examined the association between pathologic characteristics of the breast tumor and the components of density for all participants, and stratified by symptom status at diagnosis. RESULTS: Of the 286 eligible cases, 77% were 60 years or older and mean percent density was 29.5% (SD, 14.6%). Density was not significantly associated with tumor size (P = 0.22), histologic type (P = 0.77), estrogen receptor (P = 0.11) or progesterone receptor (P = 0.37) status, mitotic activity (P = 0.12), or nuclear pleomorphism (P = 0.09; P values for percent density). An inverse association was suggested between tumor grade and percent density (32.0%, 30.3%, 26.7% for grades 1-3; P = 0.06 for trend). The inverse association with tumor grade and its components (nuclear pleomorphism and tubular differentiation) was only evident among the 97 symptomatic women; positive associations of estrogen receptor (P = 0.009) and progesterone receptor (P = 0.04) were also seen with percent density only in this subgroup. CONCLUSIONS: The inverse association between tumor grade and percent density in the symptomatic population could inform the biology of the association between mammographic density and breast cancer risk.
Authors: Norman F Boyd; Helen Guo; Lisa J Martin; Limei Sun; Jennifer Stone; Eve Fishell; Roberta A Jong; Greg Hislop; Anna Chiarelli; Salomon Minkin; Martin J Yaffe Journal: N Engl J Med Date: 2007-01-18 Impact factor: 91.245
Authors: Celine M Vachon; V Shane Pankratz; Christopher G Scott; Shaun D Maloney; Karthik Ghosh; Kathleen R Brandt; Tia Milanese; Michael J Carston; Thomas A Sellers Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-05 Impact factor: 4.254
Authors: M T Mandelson; N Oestreicher; P L Porter; D White; C A Finder; S H Taplin; E White Journal: J Natl Cancer Inst Date: 2000-07-05 Impact factor: 13.506
Authors: Gareth J R Porter; Andrew J Evans; Eleanor J Cornford; Helen C Burrell; Jonathan J James; Andrew H S Lee; Jayeta Chakrabarti Journal: AJR Am J Roentgenol Date: 2007-03 Impact factor: 3.959
Authors: Salem Alowami; Sandra Troup; Sahar Al-Haddad; Iain Kirkpatrick; Peter H Watson Journal: Breast Cancer Res Date: 2003-07-23 Impact factor: 6.466
Authors: Amanda I Phipps; Christopher I Li; Karla Kerlikowske; William E Barlow; Diana S M Buist Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-05-25 Impact factor: 4.254
Authors: Karla Kerlikowske; Andrea J Cook; Diana S M Buist; Steve R Cummings; Celine Vachon; Pamela Vacek; Diana L Miglioretti Journal: J Clin Oncol Date: 2010-07-19 Impact factor: 44.544
Authors: Karla Kerlikowske; Charlotte C Gard; Jeffrey A Tice; Elad Ziv; Steven R Cummings; Diana L Miglioretti Journal: J Natl Cancer Inst Date: 2016-12-31 Impact factor: 13.506
Authors: Amanda I Phipps; Diana S M Buist; Kathleen E Malone; William E Barlow; Peggy L Porter; Karla Kerlikowske; Ellen S O'Meara; Christopher I Li Journal: Ann Epidemiol Date: 2012-02-25 Impact factor: 3.797
Authors: Lusine Yaghjyan; Rulla M Tamimi; Kimberly A Bertrand; Christopher G Scott; Matthew R Jensen; V Shane Pankratz; Kathy Brandt; Daniel Visscher; Aaron Norman; Fergus Couch; John Shepherd; Bo Fan; Yunn-Yi Chen; Lin Ma; Andrew H Beck; Steven R Cummings; Karla Kerlikowske; Celine M Vachon Journal: Breast Cancer Res Treat Date: 2017-06-17 Impact factor: 4.872
Authors: Jingmei Li; Louise Eriksson; Keith Humphreys; Kamila Czene; Jianjun Liu; Rulla M Tamimi; Sara Lindström; David J Hunter; Celine M Vachon; Fergus J Couch; Christopher G Scott; Pagona Lagiou; Per Hall Journal: Breast Cancer Res Date: 2010-03-09 Impact factor: 6.466